Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qianhai Fund of Funds is one of China's largest commercial fund of funds, established in 2015 and headquartered in the Qianhai district of Shenzhen. Founded by Jin Haitao, the former chairman of Shenzhen Capital Group, the fund operates using a unique dual model that combines fund-of-funds investment with direct equity investments. It has a multi-sector focus that heavily emphasizes healthcare, biotechnology, TMT, and advanced manufacturing. Within the life sciences sector, it acts as both a Limited Partner to specialized healthcare venture capital firms and a direct investor in high-growth biotech and medical device companies. The firm is recognized for its massive scale and its role in fostering innovation within the Chinese industrial ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qianhai Fund of Funds.